These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27365205)

  • 1. Interventions to strengthen the HIV prevention cascade: a systematic review of reviews.
    Krishnaratne S; Hensen B; Cordes J; Enstone J; Hargreaves JR
    Lancet HIV; 2016 Jul; 3(7):e307-17. PubMed ID: 27365205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study.
    Garnett GP; Hallett TB; Takaruza A; Hargreaves J; Rhead R; Warren M; Nyamukapa C; Gregson S
    Lancet HIV; 2016 Jul; 3(7):e297-306. PubMed ID: 27365204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strengthening the HIV prevention cascade to maximise epidemiological impact in eastern Zimbabwe: a modelling study.
    Pickles M; Gregson S; Moorhouse L; Dadirai T; Dzamatira F; Mandizvidza P; Maswera R; Museka T; Schaefer R; Skovdal M; Thomas R; Tsenesa B; Mugurungi O; Nyamukapa C; Hallett TB
    Lancet Glob Health; 2023 Jul; 11(7):e1105-e1113. PubMed ID: 37349036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximising HIV prevention by balancing the opportunities of today with the promises of tomorrow: a modelling study.
    Smith JA; Anderson SJ; Harris KL; McGillen JB; Lee E; Garnett GP; Hallett TB
    Lancet HIV; 2016 Jul; 3(7):e289-96. PubMed ID: 27365203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV prevention cascade: integrating theories of epidemiological, behavioural, and social science into programme design and monitoring.
    Hargreaves JR; Delany-Moretlwe S; Hallett TB; Johnson S; Kapiga S; Bhattacharjee P; Dallabetta G; Garnett GP
    Lancet HIV; 2016 Jul; 3(7):e318-22. PubMed ID: 27365206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
    Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the impact of increasing condom use or HIV pre-exposure prophylaxis (PrEP) use among female sex workers.
    Mukandavire Z; Mitchell KM; Vickerman P
    Epidemics; 2016 Mar; 14():62-70. PubMed ID: 26972515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study.
    Cremin I; McKinnon L; Kimani J; Cherutich P; Gakii G; Muriuki F; Kripke K; Hecht R; Kiragu M; Smith J; Hinsley W; Gelmon L; Hallett TB
    Lancet HIV; 2017 May; 4(5):e214-e222. PubMed ID: 28233660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Spear and Shield intervention to increase the availability and acceptability of voluntary medical male circumcision in Zambia: a cluster randomised controlled trial.
    Weiss SM; Zulu R; Jones DL; Redding CA; Cook R; Chitalu N
    Lancet HIV; 2015 May; 2(5):e181-9. PubMed ID: 26120594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [10 years' research in the social sciences on AIDS in Burkina Faso. Elements for prevention].
    Desclaux A
    Sante; 1997; 7(2):127-34. PubMed ID: 9273119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection?
    Pialoux G; Delaugerre C; Cotte L; Raffi F; Cua E; Molina JM
    Clin Microbiol Infect; 2016 Sep; 22(9):757-767. PubMed ID: 27615724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.
    Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM;
    Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motives of Dutch men who have sex with men for daily and intermittent HIV pre-exposure prophylaxis usage and preferences for implementation: A qualitative study.
    Bil JP; van der Veldt WM; Prins M; Stolte IG; Davidovich U
    Medicine (Baltimore); 2016 Sep; 95(39):e4910. PubMed ID: 27684827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Why should I take drugs for your infection?": outcomes of formative research on the use of HIV pre-exposure prophylaxis in Nigeria.
    Idoko J; Folayan MO; Dadem NY; Kolawole GO; Anenih J; Alhassan E
    BMC Public Health; 2015 Apr; 15():349. PubMed ID: 25881087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS in rural Africa: a paradigm for HIV-1 prevention.
    Hudson CP
    Int J STD AIDS; 1996 Jul; 7(4):236-43. PubMed ID: 8876353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of HIV infection in developing countries.
    d'Cruz-Grote D
    Lancet; 1996 Oct; 348(9034):1071-4. PubMed ID: 8874461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the female condom in Africa].
    Deniaud F
    Sante; 1997; 7(6):405-15. PubMed ID: 9503499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demand creation for primary biomedical prevention: identifying lessons across interventions to inform daily oral preexposure prophylaxis programs.
    Bass E; Fitch L; Gomez A; Loar R
    Curr Opin HIV AIDS; 2019 Jan; 14(1):28-40. PubMed ID: 30451699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.